Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ACTR5
REST API REST API
Homo sapiens
ACTR5 is differentially expressed in 204 experiments: 127 organism parts: testis, cerebellum, ... (125 more);, 193 disease states: normal, colon carcinoma, ... (191 more);, 69 cell types 350 cell lines 30 compound treatments and 71 other conditions.
Synonyms INO80M, FLJ12785, Arp5
Orthologs ARP5 (Saccharomyces cerevisiae)   actr5 (Danio rerio)   ARP5_CHICK (Gallus gallus)   Actr5 (Mus musculus)   Actr5 (Rattus norvegicus)   Arp5 (Drosophila melanogaster)   actr5 (Xenopus laevis)   ACTR5 (Bos taurus)   ACTR5 (Canis familiaris)   (Compare orthologs)
InterPro Term Actin-like
Gene Ontology Term protein binding, regulation of transcription, DNA-dependent, cytoplasm, Ino80 complex, double-strand break repair, ATP binding, nucleus, DNA recombination, UV-damage excision repair
UniProt Accession Q9H9F9
Search EB-eye ENSG00000101442
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MEXP-1251, E-MTAB-24, ... (20 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, ... (35 experiments)

Factor Value U/D Experiments
MCF-7
3
 E-GEOD-20081, E-GEOD-19639, E-GEOD-3529
HepG2
2
 E-GEOD-21154, E-MTAB-37
K562
2
 E-GEOD-24147, E-MTAB-37
MDA-MB-231
2
 E-TABM-420, E-MTAB-62
MOLT4
2
 E-MTAB-37, E-MTAB-62
Beas2B
1
 E-GEOD-6013
344 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-3920, E-MEXP-750, E-GEOD-4219, E-GEOD-13987, ... (34 experiments)

Factor Value U/D Experiments
memory B cell
2
 E-TABM-702, E-MEXP-2360
CD56+ NK cells
2
 E-AFMX-5, E-TABM-145
induced pluripotent stem cell
2
 E-GEOD-18265, E-GEOD-18147
2
2
 E-TABM-145, E-TABM-130
germ cell
1
 E-MTAB-25
CXCR5(hi)ICOS(hi) CD4 T cell
1
 E-MEXP-750
63 more value(s).


Disease state

studied in E-GEOD-3307, E-MEXP-1922, E-GEOD-15960, E-MEXP-2069, E-GEOD-1577, ... (47 experiments)

Factor Value U/D Experiments
colon carcinoma
3
 E-MTAB-37, E-MTAB-62, E-GEOD-3726
extranodal NK/T-cell lymphoma
2
 E-GEOD-19067, E-TABM-702
adrenocortical carcinoma
2
 E-GEOD-10927, E-TABM-311
glioblastoma
2
 E-GEOD-4290, E-MTAB-37
multiple myeloma
2
 E-MTAB-62, E-GEOD-6691
uterine fibroid
2
 E-MTAB-62, E-GEOD-7307
187 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5258, E-TABM-782, E-GEOD-5824, E-GEOD-3720, ... (18 experiments)

Factor Value U/D Experiments
none
2
5
 E-GEOD-20719, E-GEOD-5824, E-TABM-868, E-MEXP-1601, E-TABM-782, ... (7 experiments)
unknown
1
 E-GEOD-7307
5-fluorouridine
1
1
 E-GEOD-995
control
1
 E-GEOD-3284
HMB-PP (phosphoantigen)
1
 E-MEXP-1601
5-aza-2'-deoxycytidine + trichostatin A
2
1
 E-MEXP-1269
24 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
 E-GEOD-19519
thapsigargin
1
1
 E-GEOD-19519
tunicamycin
1
 E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd38
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, E-GEOD-21610 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-4006, E-MEXP-563

Genotype
studied in E-TABM-868, E-TABM-601, E-GEOD-17347

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-MEXP-2657, E-GEOD-20504, E-GEOD-9764, E-GEOD-20505 ... (5 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-MEXP-2069, E-TABM-666, ... (23 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-GEOD-6802 ... (5 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phenotype
studied in E-GEOD-21750, E-GEOD-1657, E-GEOD-17636

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19246, E-GEOD-1343

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-GEOD-3697, E-MEXP-1857, E-MEXP-2759 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

Sex
studied in E-GEOD-19743, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

tissue (organ)
studied in E-GEOD-22601

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-19815

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271

Vehicle
studied in E-GEOD-5258

Processing time: 0.332 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM